SARAH TUCCI: Open Payments
NPI 1982989265 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$619 in 24 payments from 10 companies in 2025. Trend: 2023 $738 · 2024 $871 · 2025 $619
Food & beverage: $619
| Company | Payments | Amount |
|---|---|---|
| Endo USA, Inc. | 6 | $177 |
| Dendreon Pharmaceuticals LLC | 2 | $122 |
| AstraZeneca Pharmaceuticals LP | 4 | $79 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $68 |
| Abbott Laboratories | 2 | $49 |
| Sumitomo Pharma America, Inc. | 2 | $47 |
| Janssen Biotech, Inc. | 1 | $24 |
| Ferring Pharmaceuticals Inc. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $15 |
| Photocure Inc | 1 | $14 |
Products named: XIAFLEX, PROVENGE, LYNPARZA, Nubeqa, GEMTESA, JOT DX, ERLEADA, DIAMONDBACK CORONARY.
Industry payments across LA — which companies pay providers there.
